ALZCUR — AlzeCure Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK166.63m
- SEK120.15m
Annual cashflow statement for AlzeCure Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -77.9 | -56.4 | -38.3 | -36 | -47.9 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | -0.434 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.71 | -44 | 40.8 | 0.738 | 12 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -70.6 | -99.9 | 3.06 | -34.2 | -34.6 |
| Capital Expenditures | -0.054 | 0 | — | -0.124 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.007 | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.054 | 0 | 0.007 | -0.124 | 0 |
| Financing Cash Flow Items | — | — | 0.039 | -6.91 | -4.06 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 83.7 | 0.459 | 36.7 | 53.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -70.7 | -16.2 | 3.52 | 2.4 | 18.8 |